Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados Biol. Res. (1) Genet. Mol. Biol. (1) Autor ARANDA,EVELYN (1) Campos,Júlia F. (1) KATO,SUMIE (1) Lemos,José Alexandre Rodrigues (1) Lima,Magaly B.P.L.V. (1) MEDINA,RODOLFO A (1) Melo,Fárida C.B.C. (1) Melo,Raul Antônio Morais (1) Neves,Washington Batista das (1) OWEN,GARETH I (1) Oliveira-Filho,Aldemir Branco de (1) VERDUGO,CESAR (1) Mais... Palavra-chave Venous thrombosis (2) ABO blood group (1) Atherosclerosis cardiovascular disease (1) Estrogen (1) Factor V Leiden (1) Hormone replacement therapy (HRT) (1) Myocardial infarction (1) Oral contraceptives (1) Progestins (1) Mais... Tipo do documento Info:eu-repo/semantics/article (1) Journal article (1) Ano 2009 (1) 2003 (1) País Brazil (1) Chile (1) Idioma Inglês (2)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última The action of ovarian hormones in cardiovascular disease Biol. Res. MEDINA,RODOLFO A; ARANDA,EVELYN; VERDUGO,CESAR; KATO,SUMIE; OWEN,GARETH I. The incidence of cardiovascular disease (CAD) differs between men and women, in part because of differences in risk factors and hormones. This sexual dimorphism means a lower incidence in atherosclerotic diseases in premenopausal women, which subsequently rises in postmenopausal women to eventually equal that of men. These observations point towards estrogen and progesterone playing a lifetime protective role against CAD in women. As exogenous estrogen and estrogen plus progesterone preparations produce significant reductions in low-density lipoprotein (LDL) cholesterol levels and significant increases in high-density lipoprotein (HDL) cholesterol, this should in theory lower the risk of CAD. However, results from oral contraceptive (OC) use and combined... Tipo: Journal article Palavras-chave: Hormone replacement therapy (HRT); Oral contraceptives; Atherosclerosis cardiovascular disease; Estrogen; Progestins; Venous thrombosis; Myocardial infarction. Ano: 2003 URL: http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602003000300005 Increased risk of venous thrombosis by AB alleles of the ABO blood group and Factor V Leiden in a Brazilian population Genet. Mol. Biol. Lima,Magaly B.P.L.V.; Oliveira-Filho,Aldemir Branco de; Campos,Júlia F.; Melo,Fárida C.B.C.; Neves,Washington Batista das; Melo,Raul Antônio Morais; Lemos,José Alexandre Rodrigues. Most cases of a predisposition to venous thrombosis are caused by resistance to activated protein C, associated in 95% of cases with the Factor V Leiden allele (FVL or R506Q). Several recent studies report a further increased risk of thrombosis by an association between the AB alleles of the ABO blood group and Factor V Leiden. The present study investigated this association with deep vein thrombosis (DVT) in individuals treated at the Hemocentro de Pernambuco in northeastern Brazil. A case-control comparison showed a significant risk of thrombosis in the presence of Factor V Leiden (OR = 10.1), which was approximately doubled when the AB alleles of the ABO blood group were present as well (OR = 22.3). These results confirm that the increased risk of deep... Tipo: Info:eu-repo/semantics/article Palavras-chave: ABO blood group; Factor V Leiden; Venous thrombosis. Ano: 2009 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1415-47572009000200010 Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco